Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), CytomX Therapeutics (NASDAQ:CTMX) and Cellectar Biosciences (NASDAQ:CLRB).
Spero Therapeutics has a consensus price target of $5.67.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.225 last updated October 31, 2024 at 10:14 AM EDT.
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
Spero Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.